PUBLIC EVIDENCE LAB

Inspect Timory's source links, recurrence rules and explicit unknowns.

Get the weekly brief →

Name a market. We will look for recurring, source-linked evidence—not tell you what to build.

LAST COLLECTION <1h ago16041 SIGNALS9 FEEDS1266 PAYMENT-EVIDENCE SIGNALS
#DossierEvidence levelRecurrenceRecency
141 Opportunity dossier O-2653 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 1 source · 1 payment 12-week activity Recency Fading · 2026-10-13 142 Opportunity dossier O-1840 Recurring need documented in 5 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated5 items · 2 sources 12-week activity Recency Fading · 2026-10-13 143 Opportunity dossier O-1013 Recurring need documented in 4 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated4 items · 2 sources 12-week activity Recency Fading · 2026-10-13 144 Opportunity dossier O-5821 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal3 items · 1 source · 2 payment 12-week activity Recency Fading · 2026-10-13 145 Opportunity dossier O-2854 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal3 items · 1 source · 2 payment 12-week activity Recency Fading · 2026-10-13 146 Getting first users when no one knows your SaaS exists Indie developers and small teams ship their SaaS but can't get anyone to notice it, let alone find willing beta testers. Evidence levelCorroborated11 items · 3 sources 12-week activity Recency Fading · 2026-10-13 147 Opportunity dossier O-2255 Recurring need documented in 4 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated4 items · 1 source · 1 payment 12-week activity Recency Fading · 2026-10-13 148 Opportunity dossier O-0976 Recurring need documented in 4 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated4 items · 3 sources 12-week activity Recency Fading · 2026-10-13 149 Opportunity dossier O-7389 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency Fading · 2026-10-13 150 Opportunity dossier O-5066 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency Fading · 2026-10-13 151 Opportunity dossier O-4560 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency Fading · 2026-10-13 152 Opportunity dossier O-4397 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 2 payment 12-week activity Recency Fading · 2026-10-13 153 Opportunity dossier O-1649 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency Fading · 2026-10-13 154 Opportunity dossier O-0298 Recurring need documented in 4 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated4 items · 1 source · 1 payment 12-week activity Recency Fading · 2026-10-13 155 Opportunity dossier O-3240 Recurring need documented in 6 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated6 items · 2 sources 12-week activity Recency Fading · 2026-10-13 156 Opportunity dossier O-2715 Recurring need documented in 8 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated8 items · 2 sources 12-week activity Recency Fading · 2026-10-13 157 Opportunity dossier O-2074 Recurring need documented in 4 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated4 items · 2 sources 12-week activity Recency Fading · 2026-10-13 158 Opportunity dossier O-1494 Recurring need documented in 4 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated4 items · 2 sources 12-week activity Recency Fading · 2026-10-13 159 Opportunity dossier O-0940 Recurring need documented in 4 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated4 items · 2 sources 12-week activity Recency Fading · 2026-10-13 160 Opportunity dossier O-3788 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal3 items · 1 source · 1 payment 12-week activity Recency Fading · 2026-10-13

Public dossiers offer free email unlock for the full evidence chain. Free Market Watch is self-serve: name a niche, preview matching dossiers and save change alerts over Timory's shared corpus.